사회: 이창훈 (대한간학회 전북지회 총무이사)
Case Presentation: 조유리 (국립암센터)
| 13:00-13:10 | 환영사 | 조은영 (대한간학회 전북지회 회장) |
| 격려사 | 윤정환 (대한간학회 회장) | |
| 13:10-14:50 | Session 1. From HCC Surveillance to Systemic Treatment |
윤정환(서울의대), 조은영(원광의대) |
| 13:10-13:35 | HCC Risk Prediction Models for At-Risk Subjects | 전영은 (차의과학대) |
| 13:35-14:00 | Adjuvant Therapy after Curative Treatment | 조성범 (전남의대) |
| 14:00-14:25 | Combination Therapy for Intermediate-Stage HCC: TACE Plus Systemic Therapy | 김범경 (연세의대) |
| 14:25-14:50 | First-Line Systemic Therapy for Advanced HCC | 이창훈 (전북의대) |
| 14:50-15:10 | Coffee Break | |
| 15:10-16:50 | Session 2. Management of Patients Who Undergo Systemic Treatment |
임영석(울산의대), 김인희(전북의대) |
| 15:10-15:35 | Prediction of Response to Systemic Therapy | 은혁수 (충남의대) |
| 15:35-16:00 | Management of Adverse Events Associated with Systemic Therapy | 송병근 (성균관의대) |
| 16:00-16:25 | Assessment of Treatment Response | 윤재현 (전남의대) |
| 16:25-16:50 | Second-Line and Subsequent Systemic Therapies | 황상연 (동남권원자력의학원) |
| 16:50-16:55 | 폐회사 | 임영석 (대한간학회 이사장) |
| 16:55-17:00 | 경품추첨 | 이창훈 (대한간학회 전북지회 총무이사) |